Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 23,600
+400 (1.72%)
Sep 19, 2025, 3:30 PM KST
Genomictree Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -9,105 | -10,242 | -8,756 | -6,631 | -11,425 | -11,795 | Upgrade |
Depreciation & Amortization | 1,119 | 1,198 | 1,178 | 1,335 | 1,022 | 907.92 | Upgrade |
Loss (Gain) From Sale of Assets | 117.94 | 4.46 | - | -8.5 | -17.1 | -8.45 | Upgrade |
Loss (Gain) From Sale of Investments | -408.11 | -828.71 | 328.33 | 2,097 | 2,072 | -728.2 | Upgrade |
Stock-Based Compensation | 1,471 | 1,934 | 1,633 | 249.51 | 694.04 | 402.47 | Upgrade |
Provision & Write-off of Bad Debts | 33.62 | 33.62 | 188.53 | 2,064 | - | - | Upgrade |
Other Operating Activities | -2,643 | -2,937 | -3,909 | 7,075 | 764.11 | 2,252 | Upgrade |
Change in Accounts Receivable | -3,518 | 59.14 | -6,688 | -636.9 | -1,362 | -100.58 | Upgrade |
Change in Inventory | 146.73 | 199.85 | 54.74 | -303.82 | 1,000 | -964.78 | Upgrade |
Change in Accounts Payable | 52.54 | 0.1 | 3,501 | 154.42 | -728.24 | -142.42 | Upgrade |
Change in Unearned Revenue | -0.05 | 0.27 | -9.17 | -3 | 13.19 | 14.83 | Upgrade |
Change in Other Net Operating Assets | 1,050 | -3,055 | 1,597 | -1,106 | 335.58 | -80.68 | Upgrade |
Operating Cash Flow | -11,674 | -13,633 | -10,881 | 4,286 | -7,631 | -10,243 | Upgrade |
Capital Expenditures | -2,626 | -2,484 | -239.08 | -1,762 | -10,963 | -2,683 | Upgrade |
Sale of Property, Plant & Equipment | 42.84 | 1 | - | 21.36 | 52.89 | 8.45 | Upgrade |
Sale (Purchase) of Intangibles | -45.63 | -67.88 | -49.32 | -61.64 | -865.31 | -98.87 | Upgrade |
Investment in Securities | 5,252 | -11,941 | 5,522 | 13,459 | -41,774 | 13,656 | Upgrade |
Other Investing Activities | 3,189 | 3,004 | 2,885 | 2,412 | 4,478 | 3,428 | Upgrade |
Investing Cash Flow | 5,812 | -11,488 | 8,119 | 14,069 | -49,072 | 14,311 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 50,191 | 13,145 | Upgrade |
Long-Term Debt Repaid | - | -49.91 | -54.3 | -14,534 | -2,242 | -167.52 | Upgrade |
Total Debt Repaid | -49.91 | -49.91 | -54.3 | -14,534 | -2,242 | -167.52 | Upgrade |
Net Debt Issued (Repaid) | -49.91 | -49.91 | -54.3 | -14,534 | 47,949 | 12,977 | Upgrade |
Issuance of Common Stock | 168.41 | - | - | - | 4,996 | - | Upgrade |
Repurchase of Common Stock | - | - | - | -4,984 | - | - | Upgrade |
Other Financing Activities | -0 | 6,072 | -20,443 | -6.21 | 0 | -0.31 | Upgrade |
Financing Cash Flow | 118.5 | 6,022 | -20,497 | -19,525 | 62,869 | 12,977 | Upgrade |
Foreign Exchange Rate Adjustments | -74.04 | 102 | 402.28 | 2,280 | 3,654 | -3,303 | Upgrade |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - | Upgrade |
Net Cash Flow | -5,818 | -18,998 | -22,856 | 1,110 | 9,820 | 13,741 | Upgrade |
Free Cash Flow | -14,300 | -16,118 | -11,120 | 2,523 | -18,593 | -12,926 | Upgrade |
Free Cash Flow Margin | -402.20% | -682.29% | -325.32% | 8.45% | -361.76% | -1043.37% | Upgrade |
Free Cash Flow Per Share | -595.98 | -674.99 | -419.50 | 120.20 | -900.62 | -646.74 | Upgrade |
Cash Interest Paid | - | - | - | - | 45.45 | 32.43 | Upgrade |
Cash Income Tax Paid | 18.66 | -129.05 | -73.91 | 2,096 | 473.01 | -500.16 | Upgrade |
Levered Free Cash Flow | -9,154 | -10,081 | -29,381 | 20,761 | -22,739 | -8,544 | Upgrade |
Unlevered Free Cash Flow | -8,957 | -9,897 | -28,097 | 24,125 | -19,860 | -7,501 | Upgrade |
Change in Working Capital | -2,268 | -2,795 | -1,544 | -1,895 | -741.02 | -1,274 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.